|
1
|
Go AS, Mozaffarian D, Roger VL, Benjamin
EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al:
Heart disease and stroke statistics-2014 update: A report from the
American heart association. Circulation. 129:e28–e292. 2014.
View Article : Google Scholar
|
|
2
|
Goff DC Jr, Lloyd-Jones DM, Bennett G,
Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy
D, O'Donnell CJ, et al: 2013 ACC/AHA guideline on the assessment of
cardiovascular risk: A report of the American college of
cardiology/American heart association task force on practice
guidelines. Circulation. 129(25 Suppl 2): S49–S73. 2014. View Article : Google Scholar
|
|
3
|
Perk J, De Backer G, Gohlke H, Graham I,
Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, et
al: European Guidelines on cardiovascular disease prevention in
clinical practice (version 2012). The fifth joint task force of the
european society of cardiology and other societies on
cardiovascular disease prevention in clinical practice (constituted
by representatives of nine societies and by invited experts). Eur
Heart J. 33:1635–1701. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ceška R and Štulc T: Implementation of
cardiovascular disease prevention guidelines into clinical
practice: An unmet challenge? Curr Pharm Des. 21:1180–1184. 2015.
View Article : Google Scholar
|
|
5
|
van Staa TP, Gulliford M, Ng ES, Goldacre
B and Smeeth L: Prediction of cardiovascular risk using framingham,
ASSIGN and QRISK2: How well do they predict individual rather than
population risk? PLoS One. 9:e1064552014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taljaard M, Tuna M, Bennett C, Perez R,
Rosella L, Tu JV, Sanmartin C, Hennessy D, Tanuseputro P, Lebenbaum
M and Manuel DG: Cardiovascular disease population risk tool
(CVDPoRT): Predictive algorithm for assessing CVD risk in the
community setting. A study protocol. BMJ Open. 10:e0067012014.
View Article : Google Scholar
|
|
7
|
Cui J, Forbes A, Kirby A, Marschner I,
Simes J, Hunt D, West M and Tonkin A: Semi-parametric risk
prediction models for recurrent cardiovascular events in the LIPID
study. BMC Med Res Methodol. 10:272010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu F, Teng X, Yuan X, Sun J, Wu H, Zheng
Z, Tang Y and Hu S: LCK: A new biomarker candidate for the early
diagnosis of acute myocardial infarction. Mol Biol Rep.
41:8047–8053. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Duan L, Xiong X, Liu Y and Wang J:
miRNA-1: Functional roles and dysregulation in heart disease. Mol
Biosyst. 10:2775–2782. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tikkanen E, Havulinna AS, Palotie A,
Salomaa V and Ripatti S: Genetic risk prediction and a 2-stage risk
screening strategy for coronary heart disease. Arterioscler Thromb
Vasc Biol. 33:2261–2266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suresh R, Li X, Chiriac A, Goel K, Terzic
A, Perez-Terzic C and Nelson TJ: Transcriptome from circulating
cells suggests dysregulated pathways associated with long-term
recurrent events following first-time myocardial infarction. J Mol
Cell Cardiol. 74:13–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Smyth GK, Michaud J and Scott HS: Use of
within-array replicate spots for assessing differential expression
in microarray experiments. Bioinformatics. 21:2067–2075. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nogales-Cadenas R, Carmona-Saez P, Vazquez
M, Vicente C, Yang X, Tirado F, Carazo JM and Pascual-Montano A:
GeneCodis: Interpreting gene lists through enrichment analysis and
integration of diverse biological information. Nucleic Acids Res.
37:W317–W322. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Carmona-Saez P, Chagoyen M, Tirado F,
Carazo JM and Pascual-Montano A: GENECODIS: A web-based tool for
finding significant concurrent annotations in gene lists. Genome
Biol. 8:R32007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saito R, Smoot ME, Ono K, Ruscheinski J,
Wang PL, Lotia S, Pico AR, Bader GD and Ideker T: A travel guide to
cytoscape plugins. Nat Methods. 9:1069–1076. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mortensen MB and Falk E: Real-life
evaluation of European and American high-risk strategies for
primary prevention of cardiovascular disease in patients with first
myocardial infarction. BMJ Open. 4:e0059912014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Montecucco F, Carbone F, Dini FL, Fiuza M,
Pinto FJ, Martelli A, Palombo D, Sambuceti G, Mach F and De
Caterina R: Implementation strategies of systems medicine in
clinical research and home care for cardiovascular disease
patients. Eur J Intern Med. 25:785–794. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Musunuru K: Personalized genomes and
cardiovascular disease. Cold Spring Harb Perspect Med.
5:a0140682014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Freson K, De Vos R, Wittevrongel C, Thys
C, Defoor J, Vanhees L, Vermylen J, Peerlinck K and Van Geet C: The
TUBB1 Q43P functional polymorphism reduces the risk of
cardiovascular disease in men by modulating platelet function and
structure. Blood. 106:2356–2362. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang H, Ganguly A, Yin S and Cabral F:
Megakaryocyte lineage-specific class VI β-tubulin suppresses
microtubule dynamics, fragments microtubules, and blocks cell
division. Cytoskeleton (Hoboken). 68:175–187. 2011. View Article : Google Scholar
|
|
22
|
Lovering RC, Camon EB, Blake JA and Diehl
AD: Access to immunology through the gene ontology. Immunology.
125:154–160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ronca R, Gualandi L, Crescini E, Calza S,
Presta M and Dell'Era P: Fibroblast growth factor receptor-1
phosphorylation requirement for cardiomyocyte differentiation in
murine embryonic stem cells. J Cell Mol Med. 13:1489–1498. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yukawa H, Miyatake SI, Saiki M, Takahashi
JC, Mima T, Ueno H, Nagata I, Kikuchi H and Hashimoto N: In vitro
growth suppression of vascular smooth muscle cells using
adenovirus-mediated gene transfer of a truncated form of fibroblast
growth factor receptor. Atherosclerosis. 141:125–132. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Castorena-Gonzalez JA, Staiculescu MC,
Foote C and Martinez-Lemus LA: Mechanisms of the inward remodeling
process in resistance vessels: Is the actin cytoskeleton involved?
Microcirculation. 21:219–229. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Javadov S, Jang S and Agostini B:
Crosstalk between mitogen-activated protein kinases and
mitochondria in cardiac diseases: Therapeutic perspectives.
Pharmacol Ther. 144:202–225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Herrera VL, Decano JL, Giordano N, Moran
AM and Ruiz-Opazo N: Aortic and carotid arterial stiffness and
epigenetic regulator gene expression changes precede blood pressure
rise in stroke-prone Dahl salt-sensitive hypertensive rats. PLoS
One. 9:e1078882014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chan EC, Dusting GJ, Guo N, Peshavariya
HM, Taylor CJ, Dilley R, Narumiya S and Jiang F: Prostacyclin
receptor suppresses cardiac fibrosis: Role of CREB phosphorylation.
J Mol Cell Cardiol. 49:176–185. 2010. View Article : Google Scholar : PubMed/NCBI
|
